Ligand - LGND - thread for non-PhDs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand - LGND - thread for non-PhDs

LGND 194.63

-0.6%

1:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rahul Shah who wrote (37)	1/24/1997 9:35:00 AM
From: Henry Niman	of 57

Rahul, I also have heard that LGND will not be presenting at Merrill this year. Merrill used to rate LGND. They gave it their second highest rating for the short term, and their highest rating long term. I had heard that they stopped coverage because their analyst left. I'm not sure why they haven't started again (and since their old rating began well over a year ago I suspect LGND would get a high rating for both short and long term). Merrill was involved with the underwriting of the ALRIZ IPO 1 1/2 years ago. I believe Merrill also has strong ties with LGND's retinoid partner, AGN. AGN of course has been a part of takeover rumors for quite some time and it also sounded like they almost had a deal with PNU, but Volvo got in the way. I think Volvo is now out of the picture, but I think that PNU's CEO is also gone, so I'm not sure where things stand. A takeover of LGND comes up occasionally and they did just pass a shareholder's rights clause, but I think that if Merrill is not covering LGND because of an ongoing M&A, its more likely to be related to AGN than LGND. Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next